(19)
(11) EP 1 817 281 A1

(12)

(43) Date of publication:
15.08.2007 Bulletin 2007/33

(21) Application number: 05808510.1

(22) Date of filing: 18.11.2005
(51) International Patent Classification (IPC): 
C07D 207/14(2006.01)
A61K 31/40(2006.01)
(86) International application number:
PCT/IB2005/003643
(87) International publication number:
WO 2006/056884 (01.06.2006 Gazette 2006/22)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
Designated Extension States:
AL BA HR MK YU

(30) Priority: 23.11.2004 GB 0425766

(71) Applicants:
  • Pfizer Limited
    Sandwich, Kent CT13 9NJ (GB)

    GB 
  • Pfizer, Inc.
    New York, NY 10017 (US)

    AT BE BG CH CY CZ DE DK EE ES FI FR GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR 

(72) Inventors:
  • FISH, Paul, Vincent
    Ramsgate Road Sandwich Kent CT13 9NJ (GB)
  • RYCKMANS, Thomas
    Ramsgate Road Sandwich Kent CT13 9NJ (GB)
  • STOBIE, Alan
    Ramsgate Road Sandwich Kent CT13 9NJ (GB)
  • WAKENHUT, Florian
    Ramsgate Road Sandwich Kent CT13 9NJ (GB)
  • WHITLOCK, Gavin, Alistair
    Ramsgate Road Sandwich Kent CT13 9NJ (GB)

(74) Representative: Nevant, Marc 
Pfizer European Pharma Patent Department 23-25, avenue du Docteur Lannelongue
75668 Paris Cedex 14
75668 Paris Cedex 14 (FR)

   


(54) N- [(3S)- PYRROLIDIN-3-YL]- BENZAMIDE DERIVATIVES AS MONOAMINE RE-UPTAKE INHIBITORS